Pregabalin Capsule
Product Images NDC 70518-3646

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 70518-3646). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Pregabalin is a medication available in the form of 300 mg capsules packed in a container of 60 capsules. This drug is manufactured by Ascend Labs LLC and the lot number, expiration date, and source NDC are available on the package. The package insert must be referred to before using this drug. It is essential to store this medication at a temperature of 20-25°C (88-77°F) and must be kept out of the reach of children. In addition, RemedyRepack Inc., Indiana, PA 15701, repackaged it.*
FDA Label Image

Pregabalin-equation (Pregabalin Equation)

Pregabalin-equation (Pregabalin Equation)
This appears to be medical data related to calculating creatinine clearance (CLCr) for patients. The formula involves a patient's age and weight, as well as their serum creatinine level. The text provides specific values for these variables that can be used in the calculation, including a requirement that CLCr be greater than 0.85 in female patients.*
FDA Label Image

Pregabalin-figure-6 (Pregabalin Figure 6)

Pregabalin-figure-6 (Pregabalin Figure 6)
This is a report from two studies (E1 & E3) comparing the effectiveness of different doses of an unknown drug with a placebo. The data includes the percentage of participants with a certain outcome at each dose level and the total number of participants in each group. The drug had a statistically significant impact on the outcome compared to the placebo. Specific details about the drug and outcomes are not available.*
FDA Label Image

Pregabalin-figure-7 (Pregabalin Figure 7)

Pregabalin-figure-7 (Pregabalin Figure 7)
FDA Label Image

Study Dpn 1 (Pregabalin Image 1)

Study Dpn 1 (Pregabalin Image 1)
FDA Label Image

Study Sci 1 (Pregabalin Image 10)

Study Sci 1 (Pregabalin Image 10)
FDA Label Image

Pain Intensity-study Sci 2 (Pregabalin Image 11)

Pain Intensity-study Sci 2 (Pregabalin Image 11)
FDA Label Image

Study Dpn 2 (Pregabalin Image 2)

Study Dpn 2 (Pregabalin Image 2)
FDA Label Image

Study Phn 1 (Pregabalin Image 3)

Study Phn 1 (Pregabalin Image 3)
FDA Label Image

Study Phn 2 (Pregabalin Image 4)

Study Phn 2 (Pregabalin Image 4)
FDA Label Image

Study Phn 3 (Pregabalin Image 5)

Study Phn 3 (Pregabalin Image 5)
FDA Label Image

Fibromyalgia Study F1 (Pregabalin Image 8)

Fibromyalgia Study F1 (Pregabalin Image 8)
FDA Label Image

Fibromyalgia Study F2 (Pregabalin Image 9)

Fibromyalgia Study F2 (Pregabalin Image 9)
FDA Label Image

Pregabalin Structure (Pregabalin Srtuc 1)

Pregabalin Structure (Pregabalin Srtuc 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.